Swiss National Bank’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-373,180
Closed -$37.9M 2322
2025
Q4
$37.9M Buy
373,180
+7,400
+2% +$594K 0.02% 496
2025
Q3
$20M Buy
365,780
+11,400
+3% +$570K 0.01% 647
2025
Q2
$18.8M Sell
354,380
-167,500
-32% -$8.51M 0.01% 641
2025
Q1
$22.6M Hold
521,880
0.02% 587
2024
Q4
$29.3M Sell
521,880
-25,800
-5% -$1.61M 0.02% 546
2024
Q3
$37.3M Buy
547,680
+12,600
+2% +$711K 0.02% 512
2024
Q2
$22.6M Sell
535,080
-6,500
-1% -$358K 0.02% 601
2024
Q1
$37.4M Sell
541,580
-23,400
-4% -$1.48M 0.03% 502
2023
Q4
$41.8M Sell
564,980
-15,300
-3% -$1M 0.03% 468
2023
Q3
$39.6M Sell
580,280
-63,200
-10% -$5.36M 0.03% 461
2023
Q2
$60.4M Sell
643,480
-59,900
-9% -$4.67M 0.04% 390
2023
Q1
$47.7M Sell
703,380
-15,800
-2% -$1.02M 0.03% 460
2022
Q4
$35.6M Sell
719,180
-43,237
-6% -$1.77M 0.03% 531
2022
Q3
$24.8M Buy
762,417
+7,100
+0.9% +$293K 0.02% 592
2022
Q2
$29.8M Buy
755,317
+8,900
+1% +$476K 0.02% 569
2022
Q1
$52.2M Buy
746,417
+92,800
+14% +$6.78M 0.03% 501
2021
Q4
$50.9M Sell
653,617
-24,500
-4% -$2.16M 0.03% 490
2021
Q3
$64.7M Sell
678,117
-11,500
-2% -$1.21M 0.04% 427
2021
Q2
$85.7M Buy
689,617
+77,993
+13% +$9.31M 0.05% 350
2021
Q1
$80.6M Buy
611,624
+12,000
+2% +$1.64M 0.05% 350
2020
Q4
$79.4M Buy
599,624
+16,700
+3% +$2.02M 0.06% 326
2020
Q3
$59.4M Sell
582,924
-2,200
-0.4% -$190K 0.05% 373
2020
Q2
$50.9M Buy
585,124
+15,500
+3% +$1.24M 0.04% 400
2020
Q1
$33M Buy
569,624
+108,700
+24% +$8.82M 0.04% 449
2019
Q4
$42.6M Buy
460,924
+34,480
+8% +$3.03M 0.04% 415
2019
Q3
$38.5M Buy
426,444
+16,444
+4% +$1.87M 0.04% 429
2019
Q2
$48.4M Buy
410,000
+186,081
+83% +$18.7M 0.05% 369
2019
Q1
$19.4M Buy
223,919
+6,900
+3% +$587K 0.02% 583
2018
Q4
$13.7M Buy
217,019
+4,400
+2% +$302K 0.02% 606
2018
Q3
$16.8M Buy
212,619
+2,000
+0.9% +$130K 0.02% 611
2018
Q2
$12.6M Buy
210,619
+3,000
+1% +$161K 0.01% 654
2018
Q1
$8.37M Buy
207,619
+4,800
+2% +$234K 0.01% 787
2017
Q4
$10.7M Buy
202,819
+6,100
+3% +$326K 0.01% 684
2017
Q3
$9.27M Hold
196,719
0.01% 720
2017
Q2
$6.96M Buy
196,719
+17,400
+10% +$537K 0.01% 813
2017
Q1
$4.24M Buy
179,319
+1,700
+1% +$33.7K 0.01% 1077
2016
Q4
$2.37M Buy
177,619
+4,500
+3% +$72.6K ﹤0.01% 1442
2016
Q3
$3.21M Buy
173,119
+16,819
+11% +$296K 0.01% 1195
2016
Q2
$1.92M Buy
156,300
+5,000
+3% +$37.7K ﹤0.01% 1535
2016
Q1
$983K Buy
151,300
+29,200
+24% +$187K ﹤0.01% 1902
2015
Q4
$1.13M Hold
122,100
﹤0.01% 1726
2015
Q3
$2.2M Buy
122,100
+22,500
+23% +$517K 0.01% 1235
2015
Q2
$2.96M Buy
99,600
+5,600
+6% +$141K 0.01% 1070
2015
Q1
$2.07M Buy
94,000
+2,100
+2% +$53.3K 0.01% 1263
2014
Q4
$2.52M Buy
91,900
+1,500
+2% +$36.5K 0.01% 1110
2014
Q3
$1.75M Hold
90,400
0.01% 1282
2014
Q2
$1.54M Buy
90,400
+8,700
+11% +$120K 0.01% 1432
2014
Q1
$1.16M Buy
81,700
+18,700
+30% +$253K ﹤0.01% 1615
2013
Q4
$736K Hold
63,000
﹤0.01% 1746
2013
Q3
$744K Buy
63,000
+300
+0.5% +$3.85K ﹤0.01% 1659
2013
Q2
$872K Buy
+62,700
New +$681K ﹤0.01% 1522

Other funds holding EXAS

Swiss National Bank's EXAS Position: Q1 2026 in Review

Swiss National Bank sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 373,180 shares — an estimated $37.9M sold.

Swiss National Bank first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $85.7M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Swiss National Bank reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Swiss National Bank sold 373,180 Exact Sciences shares in Q1 2026, an estimated $37.9M.
  • Swiss National Bank first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Swiss National Bank's Exact Sciences position peaked at $85.7M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.